HCPCS Codes Similar to G9653

HCPCS Codes Similar to “G9653” Code.
Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

G9652 Patient has been treated with a systemic or biologic medication for psoriasis for at least six months Code added date: 20160101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9764 Patient has been treated with a systemic medication for psoriasis vulgaris Code added date: 20170101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
G9649 Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) Code added date: 20160101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	G9651 Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented Code added date: 20160101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
M1003 Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy Code added date: 20190101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	G2182 Patient receiving first-time biologic and/or immune response modifier therapy Code added date: 20210101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
C9770 Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent Code added date: 20210101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	C9789 Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed Code added date: 20231001 Code effective date: 20231001 TXT \| PDF \| XML \| JSON
G9359 Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier Code added date: 20140101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	G9506 Biologic immune response modifier prescribed Code added date: 20160101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
Q4142 Xcm biologic tissue matrix, per square centimeter Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON	G9765 Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi Code added date: 20170101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
G6 Esrd patient for whom less than six dialysis sessions have been provided in a month Code added date: 19980501 Code effective date: 19980501 TXT \| PDF \| XML \| JSON	G8126 Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase Code added date: 20060101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON